Alexion-AstraZeneca Rare Disease

Alexion-AstraZeneca Rare Disease is dedicated to pioneering new possibilities for the rare disease community. For over three decades, it has been a leader in the rare disease sector, driven by a mission to change what it means to live with a rare disease. The company leverages innovative modalities to build a diversified pipeline, focusing on translating complex biology into novel medicines to address significant unmet needs.

As part of AstraZeneca, Alexion-AstraZeneca Rare Disease fosters a culture committed to pushing boundaries and accelerating the discovery of life-changing treatments. Headquartered in Boston, Massachusetts, the company is continually expanding its global geographic footprint, with offices around the world, to serve more rare disease patients. We invite you to learn more about our impact and explore opportunities to join our global team.